Synergy between anti-CCL2 and Docetaxel as determined by DW-MRI in a Metastatic Bone Cancer Model

Metastatic prostate cancer continues to be the second leading cause of cancer death in American men with an estimated 28,660 deaths in 2008. Recently, monocyte chemoattractant protein-1 (MCP-1, CCL2) has been identified as an important factor in the regulation of prostate metastasis. CCL2, shown to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cell Biochem
Prif Awduron: Rozel, Stefan, Galbán, Craig J., Nicolay, Klaas, Lee, Kuei C., Sud, Sudha, Neeley, Chris, Snyder, Linda A., Chenevert, Thomas L., Rehemtulla, Alnawaz, Ross, Brian D., Pienta, Kenneth J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2009
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293017/
https://ncbi.nlm.nih.gov/pubmed/19259948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.22056
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg